Human dosimetry of free (211)At and meta-[(211)At]astatobenzylguanidine ((211)At-MABG) estimated using preclinical biodistribution from normal mice

BACKGROUND: (211)At is one of the ideal nuclides for targeted radionuclide therapies (TRTs). Meta-[(211)At]astatobenzylguanidine ((211)At-MABG) has been proposed for the treatment of pheochromocytoma. To effectively use these radiopharmaceuticals, dosimetry must be performed. It is important to dete...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:EJNMMI Phys
मुख्य लेखकों: Ukon, Naoyuki, Zhao, Songji, Washiyama, Kohshin, Oriuchi, Noboru, Tan, Chengbo, Shimoyama, Saki, Aoki, Miho, Kubo, Hitoshi, Takahashi, Kazuhiro, Ito, Hiroshi
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer International Publishing 2020
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509022/
https://ncbi.nlm.nih.gov/pubmed/32960387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40658-020-00326-7
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन